The Valley Desk

LetterAmerican journal of hematologyPublished

The FLT3N701K mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Letter
Venue
American journal of hematology
Published
Subject terms
Humans; Aniline Compounds; Phenylurea Compounds; Pyrazines; Antineoplastic Agents; Protein Kinase Inhibitors; Mutation; fms-Like Tyrosine Kinase 3; Benzothiazoles; Leukemia, Myeloid, Acute
PubMed ID
37815132
PubMed Central ID
PMC10842343
Added to directory
Source checked

Report a correction or request removal